← Human Trials & Peer-Reviewed Studies
Intranasal oxytocin increases breast milk oxytocin, but has a reduced effect in depressed mothers: A randomized controlled trial
Plain-language guide to PMID 39891981 (2025): double-blind randomized controlled trial study of Oxytocin.
Key Facts
- PMID
- 39891981
- Journal
- Psychoneuroendocrinology
- Year
- 2025
- Study type
- Randomized Controlled Trial
- Authors
- Lindley Baron-Cohen K et al. (7 authors)
- DOI
- 10.1016/j.psyneuen.2025.107374
What This Study Did, in Plain Language
What Was Tested
Researchers studied Oxytocin in this randomized controlled trial publication.
Oxytocin (OT) plays pivotal roles in stress regulation, mother-infant bonding, and breastfeeding, all of which are adversely impacted by postnatal depression (PND).
In a double-blind, randomized controlled trial, the researchers assessed endogenous OT concentrations first in the breast milk of new mothers at baseline, and second following the administration of exogenous OT compared to a placebo delivered via a nasal spray.
Who Took Part
The age groups tagged for this paper are infants, young adults and adults, women only.
Participants were mothers (N = 62, aged 23-42 years) and their infants (aged 3-9 months).
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
Because people in this Oxytocin study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
As a double-blind Oxytocin study, the assignments were hidden from both participants and investigators until the end.
A placebo (an inactive look-alike) gave the Oxytocin group a baseline to be compared against.
Each mother underwent screening for PND symptoms using the Edinburgh Postnatal Depression Scale (EPDS).
N = 26 mothers scored above the cut-off point (≥9) on the EPDS, and N = 36 mothers scored below.
Breast milk samples, collected during breastfeeding, were assayed for OT content.
What Was Measured
In a double-blind, randomized controlled trial, the researchers assessed endogenous OT concentrations first in the breast milk of new mothers at baseline, and second following the administration of exogenous OT compared to a placebo delivered via a nasal spray.
Topics PubMed links to this paper include Oxytocin, Milk, Human, Depression, Postpartum, Mothers, Breast Feeding and Mother-Child Relations.
Author keywords: Breast milk, Mood and Postnatal depression.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Oxytocin.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2025 (Psychoneuroendocrinology), a journal based in England.
More context: the Oxytocin compound page, all human trials.
Our Notes on the Compound
Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.